Cost-effectiveness of overactive bladder treatments from a US commercial and payer perspective

• Päätekijät: Brian Murray (Tekijä), Jennifer Miles-Thomas (Tekijä), Amy J Park (Tekijä), Victor B Nguyen (Tekijä), Amy Tung (Tekijä), Patrick Gillard (Tekijä), Anjana Lalla (Tekijä), Victor W Nitti (Tekijä), Christopher J Chermansky (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Becaris Publishing Limited, 2023-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Aim: The cost-effectiveness of treatment options (anticholinergics, β3-adrenoceptor agonists, onabotulinumtoxinA, sacral nerve stimulation and percutaneous tibial stimulation [the latter two including new rechargeable neurostimulators]) for the management of overactive bladder (OAB) were compared wi...